Pay in 4 interest-free payments of $5.07 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Studies show by inhibiting NNMT, the 5 amino compound prevents unnecessary methylation of nicotinamide, thus preserving NAD+ for energy metabolism
SLU-PP-332 has been approved by several regulatory bodies, such as the FDA, EMA, and PMDA
No receptor fatigue was observed
This safety profile, demonstrated across multiple clinical trials for metabolic applications, may make it suitable for long-term joint support applications without the risks associated with traditional GH therapy
Mean elapsed time between initial and follow up lidocaine dosing was 39 +/- 20 minutes
US$ 26.34
US$ 21.31
,aspect=ignore)
US$ 27.91
US$ 22.59
US$ 29.37
US$ 25.59
